Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.57 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.51 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prenylhydroquinone SCHEMBL5823293 | 0.91 | HTT (0.59) | HTTPTGS1PTGS2HPGDALDH1A1 | |
| Geroquinol SCHEMBL29929565 | 0.85 | ALOX5 (0.57) | PTPN1MAOB | |
| Geroquinol SCHEMBL557012 | 0.85 | ALOX5 (0.57) | PTPN1MAOB | |
| Geroquinol SCHEMBL557013 | 0.85 | ALOX5 (0.57) | PTPN1MAOB | |
| SCHEMBL8698637 | 0.84 | TYR (0.54) | HTTPTGS1PTGS2HPGDALDH1A1 | |
| SCHEMBL8017471 | 0.84 | ALOX5 (0.59) | PTPN1MAOB | |
| SCHEMBL2943955 | 0.84 | ALOX5 (0.59) | PTPN1MAOB | |
| Geranylgeranylhydroquinone SCHEMBL8025990 | 0.84 | ALOX5 (0.59) | PTPN1MAOB | |
| SCHEMBL31536036 | 0.84 | ALOX5 (0.59) | PTPN1MAOB | |
| SCHEMBL19600971 | 0.83 | PTGS1 (0.46) | HTTPTGS1PTGS2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212176-B1 | PANICEIN COMPOUNDS, COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | CENTRE NAT RECH SCIENT (FR) | 2020-11-04 | — | — | EP | disclosed |
| US-20170326076-A1 | PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-11-16 | — | — | US | disclosed |
| WO-2017004730-A1 | PESTICIDE COMPOSITION COMPRISING TWO ACETYLATED COMPOUNDS OF PRENYLATED HYDROQUINONE AND ORCINOL COMPOUNDS AND USE THEREOF AS FUNGICIDES IN CONTROLLING BOTRYTIS CINEREA | UNIVERSIDAD TÉCNICA FEDERICO SANTA MARÍA (CL) | 2017-01-12 | — | — | WO | disclosed |
| WO-2016066594-A1 | PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-05-06 | — | — | WO | disclosed |
| US-7410998-B2 | Inhibitors of NADH:ubiquinone oxidoreductase | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-08-12 | — | — | US | disclosed |
| US-7314693-B2 | Electrophotographic photoconductor, electrophotographic process, electrophotographic apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2008-01-01 | — | — | US | disclosed |
| WO-2002100478-A9 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2002100478-A2 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2002-12-19 | — | — | WO | disclosed |
| US-4594460-A | Process for selective C-alkylation of phenols | RHONE-POULENC SANTE (FR) | 1986-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170326076-A1 | PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF | ABCC1, ABCB1, SLC47A1 | HTT 3273/4885PTGS1 871/4885PTGS2 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.